$343 Million is the total value of Eversept Partners, LP's 52 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 75.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMRN | Buy | AMARIN CORP PLCspons adr new | $42,771,558 | +148.7% | 2,060,287 | +63.1% | 12.48% | +34.0% |
| GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $34,065,052 | +67.1% | 803,185 | +51.7% | 9.94% | -10.0% |
| RCM | Buy | R1 RCM INC | $28,658,583 | +53.4% | 2,963,659 | +26.2% | 8.36% | -17.3% |
| DHR | Buy | DANAHER CORPORATION | $20,985,459 | +325.1% | 158,764 | +232.1% | 6.12% | +129.0% |
| NUVA | New | NUVASIVE INC | $18,774,831 | – | 330,601 | +100.0% | 5.48% | – |
| SNY | Buy | SANOFIsponsored adr | $14,718,761 | +10.7% | 332,402 | +8.5% | 4.29% | -40.4% |
| RDUS | Buy | RADIUS HEALTH INC | $12,869,615 | +41.4% | 645,417 | +16.9% | 3.75% | -23.8% |
| EHTH | New | EHEALTH INC | $12,508,459 | – | 200,649 | +100.0% | 3.65% | – |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $12,157,939 | +1172.2% | 103,296 | +577.2% | 3.55% | +586.1% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $9,961,185 | +125.4% | 83,574 | +106.4% | 2.91% | +21.4% |
| ENSG | Buy | ENSIGN GROUP INC | $8,174,251 | +146.0% | 159,545 | +86.4% | 2.38% | +32.6% |
| ABMD | Buy | ABIOMED INC | $7,807,745 | +72.3% | 27,339 | +96.1% | 2.28% | -7.1% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $7,032,225 | +16.3% | 38,229 | +4.8% | 2.05% | -37.4% |
| FATE | Buy | FATE THERAPEUTICS INC | $6,149,693 | +190.5% | 350,011 | +112.1% | 1.79% | +56.5% |
| TGTX | Buy | TG THERAPEUTICS INC | $6,018,696 | +2158.4% | 748,594 | +1051.7% | 1.76% | +1119.4% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $5,812,527 | +297.3% | 250,432 | +259.3% | 1.70% | +114.1% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $5,220,051 | +305.2% | 214,112 | +136.8% | 1.52% | +118.2% |
| ARGX | Buy | ARGENX SEsponsored adr | $4,910,457 | +33.7% | 39,334 | +2.9% | 1.43% | -28.0% |
| ICPT | New | INTERCEPT PHARMACEUTICALS INcall | $4,899,468 | – | 43,800 | +100.0% | 1.43% | – |
| PTCT | New | PTC THERAPEUTICS INC | $3,786,584 | – | 100,600 | +100.0% | 1.10% | – |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS | $3,360,811 | +154.0% | 412,876 | +151.8% | 0.98% | +36.9% |
| ARQL | Buy | ARQULE INC | $3,098,737 | +224.6% | 646,918 | +87.7% | 0.90% | +74.9% |
| TLGT | Buy | TELIGENT INC NEW | $2,986,864 | -3.0% | 2,574,883 | +14.6% | 0.87% | -47.8% |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $2,647,835 | – | 195,701 | +100.0% | 0.77% | – |
| DERM | New | DERMIRA INC | $2,432,225 | – | 179,500 | +100.0% | 0.71% | – |
| XENE | Buy | XENON PHARMACEUTICALS INC | $2,279,294 | +76.1% | 224,340 | +9.4% | 0.66% | -5.1% |
| MDCO | New | MEDICINES CO | $2,129,790 | – | 76,200 | +100.0% | 0.62% | – |
| TCDA | Buy | TRICIDA INC | $1,911,999 | +100.1% | 49,508 | +22.2% | 0.56% | +7.9% |
| MYOK | New | MYOKARDIA INC | $1,822,353 | – | 35,052 | +100.0% | 0.53% | – |
| CHRS | New | COHERUS BIOSCIENCES INC | $1,637,291 | – | 120,036 | +100.0% | 0.48% | – |
| CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $1,514,528 | – | 42,400 | +100.0% | 0.44% | – |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $1,424,891 | +284.4% | 107,296 | +127.8% | 0.42% | +107.0% |
| CNC | Buy | CENTENE CORP DEL | $1,253,160 | +152.8% | 23,600 | +448.8% | 0.37% | +36.6% |
| EIGR | New | EIGER BIOPHARMACEUTICALS INC | $974,518 | – | 69,708 | +100.0% | 0.28% | – |
| IVC | Buy | INVACARE CORP | $661,908 | +108.3% | 79,081 | +7.0% | 0.19% | +12.2% |
| CNCE | New | CONCERT PHARMACEUTICALS INC | $569,149 | – | 47,154 | +100.0% | 0.17% | – |
| HSKA | New | HESKA CORP | $568,602 | – | 6,680 | +100.0% | 0.17% | – |
| OTIC | New | OTONOMY INC | $473,663 | – | 180,100 | +100.0% | 0.14% | – |
| PFNX | New | PFENEX INC | $467,826 | – | 75,700 | +100.0% | 0.14% | – |
| BIOS | New | BIOSCRIP INC | $246,022 | – | 123,011 | +100.0% | 0.07% | – |
| NVAX | New | NOVAVAX INCput | $79,936 | – | 145,100 | +100.0% | 0.02% | – |
| CNCE | New | CONCERT PHARMACEUTICALS INCcall | $27,761 | – | 2,300 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.